Chiesi USA Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
498
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
9
- Investments
-
6
Chiesi USA General Information
Description
Developer of products for respiratory, inflammatory, and critical care diseases, intended to facilitate the pharmaceutical industry. The company focuses on the discovery, development, and commercialization of products designed to treat asthma and critical care diseases through the regulation of the body's inflammatory response.
Contact Information
Website
www.chiesiusa.com(Operating Subsidiary)
Corporate Office
- 175 Regency Woods Place
- Suite 600
- Cary, NC 27518
- United States
Corporate Office
- 175 Regency Woods Place
- Suite 600
- Cary, NC 27518
- United States
Chiesi USA Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chiesi USA Comparisons
Industry
Financing
Details
Chiesi USA Competitors (35)
One of Chiesi USA’s 35 competitors is EyePoint, a Corporation company based in Watertown, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| EyePoint | Corporation | Watertown, MA | ||||
| Ardelyx | Formerly VC-backed | Waltham, MA | ||||
| Catalyst Pharmaceuticals | Corporate Backed or Acquired | Coral Gables, FL | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Chiesi USA Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Chiesi USA Patents
Chiesi USA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2844775-A1 | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients | Inactive | 23-Aug-2011 | ||
| EP-2747762-A1 | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients | Active | 23-Aug-2011 | ||
| EP-2747762-B1 | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients | Inactive | 23-Aug-2011 | ||
| EP-2959899-A1 | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients | Active | 23-Aug-2011 | ||
| EP-2959899-B1 | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients | Active | 23-Aug-2011 | A61K31/381 |
Chiesi USA Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Chiesi USA Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Chiesi USA Investments & Acquisitions (6)
Chiesi USA’s most recent deal was a Corporate Asset Purchase with Digestive Care (U.S. rights to market PERTZYE). The deal was made on 29-Jul-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Digestive Care (U.S. rights to market PERTZYE) | 29-Jul-2013 | Corporate Asset Purchase | Buildings and Property | ||
| EKR Therapeutics | 27-Jun-2012 | Merger/Acquisition | Pharmaceuticals | ||
| CardioKine | 04-Jan-2012 | Merger/Acquisition | Drug Discovery | ||
| MedImmune (development and commercial rights of HMGB1) | 06-Jul-2010 | Corporate Asset Purchase | Buildings and Property | ||
| Factive's North American Rights | 09-Sep-2009 | Corporate Asset Purchase | Buildings and Property |
Chiesi USA Exits (1)
Chiesi USA’s most recent exit was on 09-Sep-2009 from Factive's North American Rights. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Factive's North American Rights | 09-Sep-2009 | Completed |
|
Chiesi USA FAQs
-
When was Chiesi USA founded?
Chiesi USA was founded in 2000.
-
Where is Chiesi USA headquartered?
Chiesi USA is headquartered in Cary, NC.
-
What is the size of Chiesi USA?
Chiesi USA has 498 total employees.
-
What industry is Chiesi USA in?
Chiesi USA’s primary industry is Pharmaceuticals.
-
Is Chiesi USA a private or public company?
Chiesi USA is a Private company.
-
What is the current valuation of Chiesi USA?
The current valuation of Chiesi USA is .
-
What is Chiesi USA’s current revenue?
The current revenue for Chiesi USA is .
-
How much funding has Chiesi USA raised over time?
Chiesi USA has raised $224M.
-
Who are Chiesi USA’s investors?
Advanced Technology Ventures, HealthCare Ventures, Johnson & Johnson JJDC, MPM BioImpact, and MedImmune Ventures are 5 of 9 investors who have invested in Chiesi USA.
-
Who are Chiesi USA’s competitors?
EyePoint, Ardelyx, Catalyst Pharmaceuticals, Pfizer (Vienna), and Genentech are some of the 35 competitors of Chiesi USA.
-
When was Chiesi USA acquired?
Chiesi USA was acquired on 04-Feb-2014.
-
Who acquired Chiesi USA?
Chiesi USA was acquired by Chiesi Farmaceutici.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
